Literature DB >> 20580234

Piperidinyl-nicotinamides as potent and selective somatostatin receptor subtype 5 antagonists.

André Alker1, Alfred Binggeli, Andreas D Christ, Luke Green, Hans Peter Maerki, Rainer E Martin, Peter Mohr.   

Abstract

Nicotinamides of benzyl-substituted 4-aminopiperidines and their seven-membered analogs of generic structure 2 and 2' have been discovered as potent and selective SST5 antagonists. The activity (K(i)) ranges from 2.4 to 436 nM. Most compounds exhibit decent physicochemical properties and follow a clear SAR pattern. Interestingly enough, the receptor is strongly enantiodiscriminating and binds in the amino-azepane-series only the (R)-enantiomer. Copyright 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20580234     DOI: 10.1016/j.bmcl.2010.06.026

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  2 in total

1.  Discovery and Pharmacology of a Novel Somatostatin Subtype 5 (SSTR5) Antagonist: Synergy with DPP-4 Inhibition.

Authors:  Weiguo Liu; Pengcheng P Shao; Gui-Bai Liang; John Bawiec; Jiafang He; Susan D Aster; Margaret Wu; Garry Chicchi; John Wang; Kwei-Lan Tsao; Jin Shang; Gino Salituro; Yun-Ping Zhou; Cai Li; Taro E Akiyama; Daniel E Metzger; Beth Ann Murphy; Andrew D Howard; Ann E Weber; Joseph L Duffy
Journal:  ACS Med Chem Lett       Date:  2018-09-12       Impact factor: 4.345

2.  Optimization of Preclinical Metabolism for Somatostatin Receptor Subtype 5-Selective Antagonists.

Authors:  Weiguo Liu; Zahid Hussain; Yi Zang; Ramzi F Sweis; F Anthony Romero; Paul E Finke; Remond Moningka; Jianming Bao; Michael A Plotkin; Jin Shang; Karen H Dingley; Gino Salituro; Beth Ann Murphy; Andrew D Howard; Feroze Ujjainwalla; Harold B Wood; Joseph L Duffy
Journal:  ACS Med Chem Lett       Date:  2018-10-05       Impact factor: 4.345

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.